doi,id_outcome,Outcomes,relative_effect_95CI,n_participants_studies,n_participants,n_studies,GRADE,Comments,effect_statistic,CI_lower,CI_upper
https://doi.org/10.1002/14651858.CD012791.pub2,5,"Depressive symptoms assessed with: CESD, POMS‐depression subscale Scale from 0 to 60 follow‐up: range 7 weeks to 8 weeks",‐,135 (3 RCTs),135 ,3 RCTs),⊕⊕⊝⊝ LOW a b,Moderate effect size;c lower score represents lower depressive symptoms,SMD,NA,NA
https://doi.org/10.1002/14651858.CD012791.pub2,6,Anxiety assessed with: STAI‐state anxiety subscale Scale from 20 to 80 follow‐up: 8 weeks,‐,78 (1 RCT),78 ,1 RCT),⊕⊕⊝⊝ LOW a b,Moderate effect size;c lower score represents lower level of anxiety,mean anxiety was 47.4 score MD,NA,NA
https://doi.org/10.1002/14651858.CD012791.pub2,7,"Carer burden assessed with: MBCBS‐subjective stress burden, RMBPC‐reaction, ZBI Scale from 0 to 100 follow‐up: range 7 weeks to 8 weeks",‐,135 (3 RCTs),135 ,3 RCTs),⊕⊕⊝⊝ LOW a b,Small effect size;c lower score represents lower level of carer burden,SMD,NA,NA
https://doi.org/10.1002/14651858.CD012791.pub2,8,Dropout rates follow‐up: range 7 weeks to 8 weeks,RR 1.39 (0.32 to 5.99),166 (4 RCTs),166 ,4 RCTs),⊕⊝⊝⊝ VERY LOW a d,Important effect sizee,RR,0.32,5.99
https://doi.org/10.1002/14651858.CD012791.pub2,9,Dropout rates follow‐up: range 7 weeks to 8 weeks,RR 1.39 (0.32 to 5.99),166 (4 RCTs),166 ,4 RCTs),⊕⊝⊝⊝ VERY LOW a d,122 per 1000 (28 to 524),RR,0.32,5.99
